参考文献/References:
[1]KRAMER A, PIPPIAS M, NOORDZIJ M,et al. The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary[J].Clinical Kidney,2018,11(1): 108-122.[2]金其庄,王玉柱,叶朝阳,等.中国血液透析用血管通路专家共识(第2版)[J].中国血液净化,2019,18(6):365-381.[3]TLILI I, RAMZAN M, KADRY S,et al. Radiative MHD nanofluid flow over a moving thin needle with entropy generation in a porous medium with dust particles and hall current[J].Entropy (Basel),2020,22(3):354. [4]ALI F,IMTIAZ A,KHAN WA,et al.Effects of MHD and porosity on entropy generation in two incompressible Newtonian fluids over a thin needle in a parallel free stream[J]. Sci Rep, 2020,10(1):22305.[5]PISONI RL, ZEPEL L, PORT FK,et al. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons[J]. Am J Kidney Dis,2015,65(6):905-915.[6]赵艳红,李红梅,杨崇猛,等.终末期肾脏病患者初次HD血管通路选择及内瘘使用相关因素分析[J].河北医学,2020,26(4):635-639.[7]TAMURA A,MINAMI K,TSUDA Y,et al. Adolescent eating disorder with catheter-related bloodstream infection[J]. Pediatr Int,2021,63(6):678-684.[8]李振香,张 琦,姜腾飞,等.山东省三级医院主要院内感染指标现状与趋势分析[J].中国卫生质量管理,2019,26(3):22-25. [9]MIELKE D, WITTIG A, TEICHGRABER U.Peripherally inserted central venous catheter (PICC) in outpatient and inpatient oncological treatment[J].Support Care Cancer,2020,28(10):4753-4760.[10]国家卫生健康委办公厅.关于印发2021年国家医疗质量安全改进目标的通知:国卫办医函〔2021〕76 号 [EB/OL].(2021-02-10)[2023-08-10].https://www.gov.cn/zhengce/zhengceku/2021-02/22/co ntent_5588240.htm.[11]国家卫生健康委办公厅.关于印发2023年国家医疗质量安全改进目标的通知:国卫办医函〔2023〕45 号 [EB/OL].(2023-02-24)[2023-08-10].http://www.nhc.gov.cn/yzygj/s7657/202302/a61fc382f3 b64c7e99dafbf8cf4da8a1.shtml.[12]BROUWERS MC, KHO ME, BROWMAN GP,et al.AGREE II: advancing guideline development, reporting, and evaluation in health care[J].Preventive Medicine, 2010, 51(5):421-424.[13]熊 俊,陈日新.系统评价/Meta分析方法学质量的评价工具AMSTAR[J].中国循证医学杂志, 2011, 11(9):1084-1089.[14]胡 雁,郝玉芳.循证护理学[M].北京:人民卫生出版社,2018:45. [15]王春青,胡 雁.JBI证据预分级及证据推荐级别系统(2014版)[J].护士进修杂志, 2015, 30(11):964-967.[16]O’GRADY NP, ALEXANDER M, BURNS LA,et al.Guidelines for the prevention of intravascular catheter-related infections[J].Clin Infect Dis,2011,52(9):162-193.[17]LING ML,APISARNTHANARAK A,JAGGI N,et al.APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI)[J].Antimicrob Resist Infect Control,2016,5:16.[18]SCHMIDLI J, WIDMER MK, BASILE C,et al.Editor’s choice - vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)[J].Eur J Vasc Endovasc Surg,2018,55(6):757-818.[19]LOK CE,HUBER TS,LEE T,et al.KDOQI clinical practice guideline for vascular access: 2019 update[J].Am J Kidney Dis,2020,75(4 Suppl 2):S1-S164.[20]National Institute for Health and Care Excellence . ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections[EB/OL].(2021-12-13)[2023-12-11].https://www.nice.org.uk/guidance/mtg62.[21]BLL B, SCHALK E, BUCHHEIDT D, et al. Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)[J].Ann Hematol, 2021 ,100(1):239-259. [22]CHAVES F, GARNACHO-MONTERO J, DEL POZO JL,et al. Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)[J]. Med Intensiva (Engl Ed),2018,42(1):5-36.[23]MERMEL LA,ALLON M,BOUZA E,et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America[J].Clin Infect Dis,2010,50(7):1079.[24]中心静脉血管通路装置安全管理专家组.中心静脉血管通路装置安全管理专家共识(2019版)[J].中华外科杂志,2020,58(4):261-272. [25]陈静,向晶,接艳青,等.血液透析安全注射临床实践专家共识[J].中华护理杂志,2022,57(7):785-790.[26]蔡虻,高凤莉.导管相关感染防控最佳护理实践专家共识[M].北京:人民卫生出版社,2018:50.[27]孙红,陈利芬,郭彩霞,等.临床静脉导管维护操作专家共识[J].中华护理杂志,2019,54(9):1334-1342.[28]LAI NM,LAI NA,O’RIORDAN E,et al.Skin antisepsis for reducing central venous catheter-related infections[J].Cochrane Database Syst Rev, 2016, 7(7):CD010140.[29]豆欣蔓,谢琪,张丽红,等.经隧道式中心静脉导管行血液透析导管相关血流感染发病率及危险因素的系统评价与Meta分析[J].中国血液净化, 2023, 22(3):214-220.[30]刘锐芮,高静柏,丁 兮,等.血液透析患者导管相关血流感染危险因素的Meta分析[J].临床肾脏病杂志, 2022, 22(8):674-680.[31]NAPALKOV P,FELICI DM,CHU LK,et al.Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis[J].BMC Cardiovascular Disorders, 2013, 13:86.[32]张 月,向 晶,韦 洮,等.北京市血液净化质量控制中心医院感染质量控制策略与现状分析[J].中国血液净化, 2022,21(9):686-691,701.[33]李道新,熊 飞,李红兵,等.血液透析患者导管相关血流感染的危险因素及其预测模型构建[J].中华医院感染学杂志, 2023, 33(3):368-371.[34]中华医学会重症医学分会.血管内导管相关感染的预防与治疗指南(2007)[J].中华急诊医学杂志,2008,17(6):597-605.[35]MILLER DL, O’GRADY NP,Society of Interventional Radiology.Guidelines for the prevention of intravascular catheter-related infections:recommendations relevant to interventiona I radiology for venous catheter placement and maintenance[J].J Vasc Interv Radiol,2012,23(8):997-1007.[36]MARSCHALL J,MERMEL LA,FAKIH M,et al.Strategies to prevent central line-associated bloodstream infections in acute care hospitals:2014update[J].Infect Control Hosp Epidemiol,2014,35(7):753-771.[37]戢 敏,陈 星,刘 娇,等.静脉置管模式与HM患者CRBSI的病原菌分布及耐药性评估的相关性研究[J].中国现代医学杂志,2018,28(18):67-71.[38]周 芹,焦 河,刘春乘,等.经皮无名静脉穿刺技术建立长期血液透析通路的临床研究[J].中国血液净化,2017,16(3):204-207.[39]曾影红.ICU中心静脉置管时间与导管相关性感染的研究[J].护士进修杂志,2009,24(3):202-203.